Lynn Kirkpatrick serves as Executive at Oncothyreon Inc., where they oversee executive responsibilities. Since joining the company, Lynn Kirkpatrick has executed 5 insider transactions totaling $48.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 26, 2022 involved purchasing 27,000 shares valued at $14.3K.
Lynn Kirkpatrick currently holds 381,851 shares of Oncothyreon Inc. (ONTY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lynn Kirkpatrick has been a net buyer of ONTY stock. They have purchased $48.6K and sold $0 worth of shares.
Lynn Kirkpatrick's most recent insider trade was on May 26, 2022, when they purchased 27,000 shares at $0.53 per share.
Get notified when new Form 4 filings are submitted
| $0.49 |
| Discretionary |
| Jun 30, 2021 | ENSC | $0 | Award | 284,851 | $N/A | Discretionary |
| Dec 10, 2007 | ONTY | $0 | Other | 800,239 | $N/A | Discretionary |
| Dec 10, 2007 | ONTY | $0 | Other | 813,633 | $N/A | Discretionary |